孟麗萍


[摘要] 目的 探討個(gè)體化營(yíng)養(yǎng)治療對(duì)交界性糖耐量異常孕婦糖脂代謝及妊娠結(jié)局的影響。方法 選取2018年1—12月醫(yī)院收治的80例交界性糖耐量異常孕婦作為研究對(duì)象,隨機(jī)分為觀察組和對(duì)照組各40例。比較兩組孕婦的糖脂代謝情況、妊娠結(jié)局。 結(jié)果 觀察組治療后的糖脂代謝指標(biāo)、妊娠結(jié)局均明顯優(yōu)于對(duì)照組(P<0.05)。 結(jié)論 個(gè)體化營(yíng)養(yǎng)治療能明顯改善交界性糖耐量異常孕婦的妊娠結(jié)局及糖脂代謝水平。
[關(guān)鍵詞] 交界性糖耐量異常;孕婦;糖脂代謝;妊娠結(jié)局
[中圖分類號(hào)] R714.256? ? ? ? ? [文獻(xiàn)標(biāo)識(shí)碼] A? ? ? ? ? [文章編號(hào)] 1672-4062(2020)01(b)-0005-03
[Abstract] Objective To investigate the effects of individualized nutrition therapy on glucose and lipid metabolism and pregnancy outcome in pregnant women with borderline impaired glucose tolerance. Methods Eighty women with borderline impaired glucose tolerance who were admitted to hospital from January to December 2018 were enrolled in the study. They were randomly divided into observation group and control group. The glucose and lipid metabolism and pregnancy outcomes of the two groups of pregnant women were compared. Results The glucose and lipid metabolism indexes and pregnancy outcomes of the observation group were significantly better than those of the control group(P<0.05). Conclusion Individualized nutritional therapy can significantly improve the pregnancy outcome and glucose and lipid metabolism levels in pregnant women with borderline impaired glucose tolerance.
[Key words] Borderline impaired glucose tolerance; Pregnant women; Glycolipid metabolism; Pregnancy outcome
交界性糖耐量異常是孕婦妊娠期的一種常見并發(fā)癥,易增加其分娩時(shí)的剖宮產(chǎn)率及母嬰并發(fā)癥發(fā)生率,若未給予有效干預(yù)易導(dǎo)致孕婦進(jìn)展為妊娠期糖尿病,而妊娠期糖尿病會(huì)增加妊娠期并發(fā)癥率及不良母嬰妊娠結(jié)局風(fēng)險(xiǎn)[1]。臨床研究表明,孕期實(shí)施飲食干預(yù)有助于改善交界性糖耐量異常孕婦的妊娠結(jié)局[2]。個(gè)體化醫(yī)學(xué)營(yíng)養(yǎng)治療能夠針對(duì)不同孕婦的病情采取針對(duì)性的營(yíng)養(yǎng)治療,有助于改善孕婦妊娠期的營(yíng)養(yǎng)狀態(tài)。因此,該文選取2018年1—12月收治的80例交界性糖耐量異常孕婦作為研究對(duì)象,旨在探討個(gè)體化營(yíng)養(yǎng)治療對(duì)交界性糖耐量異常孕婦糖脂代謝及妊娠結(jié)局的影響。報(bào)道如下。
1? 資料與方法
1.1? 一般資料
該研究選取院收治的80例交界性糖耐量異常孕婦作為研究對(duì)象,隨機(jī)分為觀察組和對(duì)照組各40例。觀察組:年齡23~37歲,平均(30.24±5.42)歲;孕周22~30周,平均(26.13±1.50)周;初產(chǎn)婦24例,經(jīng)產(chǎn)婦16例。對(duì)照組:年齡22~37歲,平均(30.23±5.41)歲;孕周22~32周,平均(26.25±1.54)周;初產(chǎn)婦25例,經(jīng)產(chǎn)婦15例。患者均對(duì)該研究知情,并簽署知情同意書。……